EGFR and glioblastoma: Interestingly, although the expression or activation of EGFR failed to correlate with the outcome in TCGA data, the presence of elevated levels of specific phosphorylation sites of both EGFR and RPS6, significantly associated with poor prognosis in the same cohort of GBM patients.